Month: April 2021

HOUSTON, April 05, 2021 (GLOBE NEWSWIRE) — Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) announced they will release first-quarter 2021 earnings after market close on Tuesday, May 4, 2021 and will hold a joint webcast on the same day as follows: What: First-quarter 2021 earnings webcast When: Tuesday, May 4, 2021 5:30 p.m. ET; 4:30 p.m. CT Where: www.plainsallamerican.com or https://edge.media-server.com/mmc/p/zn5w3dqh How: Live over the internet – log on at either of the addresses above Specific items we intend to address on the call include:PAA’s first-quarter 2021 performance; Capitalization and liquidity; and Financial and operating guidanceThe slide presentation accompanying the conference call materials will be posted prior to the call at www.plainsallamerican.com under the...

HOUSTON, April 05, 2021 (GLOBE NEWSWIRE) — Mel Payne, Chairman and CEO of Carriage Services, Inc. (NYSE: CSV), issued the following statement, “Today after the market closed, we released my Shareholder Letter, along with filing a related Current Report on Form 8-K with the Securities and Exchange Commission, as my Shareholder Letter contains our Year to Date February 2021 Comparative Performance Highlights (shown below), as well as highly transparent individual performance data on the four large acquisitions we made during the last quarter of 2019/early 2020. The Cover Theme for my 50 page Shareholder Letter is, “A Tale of High Performance Transformation.” YTD February 2021 compared to YTD February 2020Record Same Store Funeral Contracts of 7,734, an increase of 29.2%; Record Total Revenue of $65.7 million, an increase of 26.9%; Record...

FOSTER CITY, Calif., April 05, 2021 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced that company management will participate in a fireside chat at the 20th Annual Needham Virtual Healthcare Conference on Monday, April 12, 2021 at 1:30 p.m. ET. A live webcast of the fireside chat can be accessed through the Investors & Media section of the Company’s website at http://investors.vaxcyte.com. A replay of the webcast will be available for approximately 30 days following the conference. About VaxcyteVaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...

MARIETTA, Ga., April 05, 2021 (GLOBE NEWSWIRE) — BlueLinx Holdings Inc. (NYSE: BXC), a leading distributor of building and industrial products in the United States, today announced that the Company repaid the outstanding principal balance under its term loan facility of approximately $16 million on April 2, 2021. The payment was funded through existing availability under the Company’s revolving credit facility. “Our voluntary repayment of the term loan reduces cash interest expense and further simplifies our capital structure, which is consistent with our disciplined approach to managing our balance sheet,” stated Kelly Janzen, CFO of BlueLinx. “Given the continued, underlying strength of our end-markets and strategic approach to managing working capital, we remain focused on deleveraging, while maintaining ample liquidity to support...

NEW HAVEN, Conn., April 05, 2021 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced two upcoming presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021, which will be held virtually from April 10-15, 2021 and May 17-21, 2021. These presentations will describe the discovery of Arvinas’ two clinical-stage PROTAC degraders, ARV-110 and ARV-471, including the first disclosures of their structures. Details for the presentations are as follows: Title: Discovery of ARV-110, a first in class androgen receptor degrading PROTAC® for the treatment of men with metastatic castration resistant prostate cancerDate and Time: April 11, 2021 from 2:05 PM – 2:15 PM ETPresenter: Lawrence B....

CLEVELAND, April 05, 2021 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc., (the “Company”) (Nasdaq: LECO) announced today that it will release its first quarter 2021 results on Tuesday, April 27, 2021 prior to market open. An investor webcast will take place at 10:00 a.m. (ET) later that day. The earnings call will be webcast live in listen-only mode on the Company’s Investor Relations web site at https://ir.lincolnelectric.com. Listeners should go to the web site prior to the call to register, download and install any necessary audio software. If investors would like to ask questions, please dial (877) 344-3899 (domestic) or (315) 625-3087 (international) and use confirmation code 1341827. Telephone participants are asked to dial in 10 to 15 minutes prior to the start of the conference call.  A replay of the earnings call...

VANCOUVER, Washington, April 05, 2021 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman and Chief Medical Officer and Christopher Recknor, M.D., Chief Operating Officer, will host an investment community webcast which is rescheduled one day later on Wednesday, April 7, 2021. Management will provide a full update to its stockholders on Company activities, including recent COVID-19 initiatives and information concerning its active trials in COVID-19, NASH and cancer. Management will provide approximately 60 minutes to address questions submitted...

LEIDEN, Netherlands and CAMBRIDGE, Mass., April 05, 2021 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today announced the closing of its previously announced underwritten public offering of 13,846,154 ordinary shares at a price to the public of $6.50 per share. All of the shares were offered by ProQR. The closing included the full exercise of the underwriters’ option to purchase up to 2,076,923 additional ordinary shares at the public offering price, less underwriting discounts and commissions. Gross proceeds from the offering totaled approximately $103.5 million, before deducting underwriting discounts and commissions and offering expenses.  Citigroup and Evercore ISI acted as joint lead...

BOCA RATON, Fla., April 05, 2021 (GLOBE NEWSWIRE) — ADT Inc. (NYSE: ADT) a leading provider of security, automation, and smart home solutions serving consumer and business customers in the United States, today announced the appointment of Sigal Zarmi to the company’s board of directors as an additional independent director. “We are pleased to welcome Sigal to our board of directors,” said Marc Becker, ADT chairman of the board. “Her extensive experience in technology and transformation will be a tremendous asset to our board and the company as ADT enters its next growth phase and creates smarter security solutions to actively protect people in ways that haven’t even been imagined.” “I am thrilled to be joining the board of ADT,” Zarmi said. “It is an exciting time for ADT as it introduces truly innovative cloud, AI and ML solutions...

NEW YORK, April 05, 2021 (GLOBE NEWSWIRE) — Staffing 360 Solutions, Inc. (NASDAQ: STAF) announced today that the Company’s Special Meeting of Stockholders, scheduled for 10:00 a.m. Eastern Time today, April 5, 2021, has been adjourned to allow for more time for stockholders to vote. The Special Meeting has been scheduled to reconvene on April 20, 2021 at 10:00 a.m. Eastern time and will be held virtually online at www.virtualshareholdermeeting.com/STAF2021SM. During the period of the adjournment, the Company will continue to solicit proxies from its stockholders with respect to the proposal set forth in the Company’s proxy statement. Proxies previously submitted in respect to the Special Meeting will be voted at the reconvened meeting unless properly revoked. The Company encourages all stockholders who have not yet voted to do so...